OSR HEALTH, INC. Proceeds from Long-Term Debt Issued
OSR HEALTH, INC. (OSRH) reported Proceeds from Long-Term Debt Issued of $236.67 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-03-31
- OSR HEALTH, INC. proceeds from issuance of long-term debt for the quarter ending 2024-12-31 was -$1.95K.
- OSR HEALTH, INC. proceeds from issuance of long-term debt for the quarter ending 2024-09-30 was -$592.00.
- OSR HEALTH, INC. proceeds from issuance of long-term debt for the quarter ending 2024-06-30 was $117.71K.
- OSR HEALTH, INC. proceeds from issuance of long-term debt for the quarter ending 2024-03-31 was $121.50K.
- OSR HEALTH, INC. proceeds from issuance of long-term debt for fiscal 2024 was $236.67K.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$1.95K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.54K derived: sum of 2 quarters · filed 2026-03-31 | $115.17K derived: sum of 3 quarters · filed 2026-03-31 | $236.67K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$592.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $117.12K derived: sum of 2 quarters · filed 2025-11-12 | $238.62K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $117.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $239.21K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $121.50K 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |